SA
CLBT icon

Strategic Advisors’s Cellebrite CLBT Stock Holding History

Strategic Advisors’s Portfolio CLBT Stock Details CLBT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$1.89M Sell
136,860
-7,180
-5% -$108K 0.31% 74
2025
Q4 		$2.6M Buy
144,040
+110
+0.1% +$1.98K 0.41% 59
2025
Q3 		$2.67M Buy
143,930
+42,903
+42% +$674K 0.43% 56
2025
Q2 		$1.62M Buy
101,027
+31,829
+46% +$567K 0.32% 68
2025
Q1 		$1.34M Buy
69,198
+40,116
+138% +$844K 0.26% 81
2024
Q4 		$641K Buy
29,082
+950
+3% +$18.3K 0.12% 124
2024
Q3 		$474K Buy
+28,132
New +$417K 0.09% 145

Other funds holding CLBT

TWCM
True Wind Capital Management San Francisco, California $226M AUM 2.79% 1-Year Est. Return
VC
Voss Capital Houston, Texas $1.88B AUM 1.03% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
PP
Pertento Partners London, United Kingdom $1.37B AUM 36.36% 1-Year Est. Return
PF
Phoenix Financial Givatayim, Israel $10.5B AUM 49.21% 1-Year Est. Return
NTCM
Nine Ten Capital Management Chicago, Illinois $315M AUM 62.95% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
CI
Clal Insurance Tel-Aviv, Israel $16.6B AUM 68.34% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Strategic Advisors's CLBT Position: Q1 2026 in Review

Strategic Advisors reduced its Cellebrite (CLBT) stake by 5% in Q1 2026, selling an estimated $108K and leaving 136,860 shares worth $1.89M. The position accounts for 0.31% of the portfolio, ranked #74.

Strategic Advisors first reported a position in CLBT in Q3 2024 and has held it in 7 quarters since. The position peaked at $2.67M in Q3 2025. 220 funds tracked by Wall St. Rank hold CLBT as of Q1 2026.

  • Strategic Advisors held 136,860 shares of Cellebrite worth $1.89M as of Q1 2026.
  • Strategic Advisors sold 7,180 Cellebrite shares in Q1 2026, an estimated $108K.
  • Cellebrite made up 0.31% of Strategic Advisors's portfolio in Q1 2026, its #74 holding.
  • Strategic Advisors first reported a position in Cellebrite in Q3 2024 and has held it in 7 quarters since.
  • Strategic Advisors's Cellebrite position peaked at $2.67M in Q3 2025.
  • 220 funds tracked by Wall St. Rank held Cellebrite as of Q1 2026.

Based on Strategic Advisors's 13F filing for Q1 2026, filed 14 May 2026.